Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
1998 6
1999 3
2000 6
2001 3
2002 1
2003 2
2004 1
2005 2
2006 5
2007 2
2008 2
2009 2
2010 2
2011 3
2012 2
2013 5
2014 3
2015 4
2016 3
2017 3
2018 8
2019 7
2020 5
2021 8
2022 13
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Risdiplam in Type 1 Spinal Muscular Atrophy.
Baranello G, Darras BT, Day JW, Deconinck N, Klein A, Masson R, Mercuri E, Rose K, El-Khairi M, Gerber M, Gorni K, Khwaja O, Kletzl H, Scalco RS, Seabrook T, Fontoura P, Servais L; FIREFISH Working Group. Baranello G, et al. N Engl J Med. 2021 Mar 11;384(10):915-923. doi: 10.1056/NEJMoa2009965. Epub 2021 Feb 24. N Engl J Med. 2021. PMID: 33626251 Clinical Trial.
Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative.
Dick AD, Rosenbaum JT, Al-Dhibi HA, Belfort R Jr, Brézin AP, Chee SP, Davis JL, Ramanan AV, Sonoda KH, Carreño E, Nascimento H, Salah S, Salek S, Siak J, Steeples L; Fundamentals of Care for Uveitis International Consensus Group. Dick AD, et al. Ophthalmology. 2018 May;125(5):757-773. doi: 10.1016/j.ophtha.2017.11.017. Epub 2018 Jan 6. Ophthalmology. 2018. PMID: 29310963 Free article.
Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls.
Darras BT, Masson R, Mazurkiewicz-Bełdzińska M, Rose K, Xiong H, Zanoteli E, Baranello G, Bruno C, Vlodavets D, Wang Y, El-Khairi M, Gerber M, Gorni K, Khwaja O, Kletzl H, Scalco RS, Fontoura P, Servais L; FIREFISH Working Group. Darras BT, et al. N Engl J Med. 2021 Jul 29;385(5):427-435. doi: 10.1056/NEJMoa2102047. N Engl J Med. 2021. PMID: 34320287
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial.
Mercuri E, Deconinck N, Mazzone ES, Nascimento A, Oskoui M, Saito K, Vuillerot C, Baranello G, Boespflug-Tanguy O, Goemans N, Kirschner J, Kostera-Pruszczyk A, Servais L, Gerber M, Gorni K, Khwaja O, Kletzl H, Scalco RS, Staunton H, Yeung WY, Martin C, Fontoura P, Day JW; SUNFISH Study Group. Mercuri E, et al. Lancet Neurol. 2022 Jan;21(1):42-52. doi: 10.1016/S1474-4422(21)00367-7. Lancet Neurol. 2022. PMID: 34942136
Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial.
Masson R, Mazurkiewicz-Bełdzińska M, Rose K, Servais L, Xiong H, Zanoteli E, Baranello G, Bruno C, Day JW, Deconinck N, Klein A, Mercuri E, Vlodavets D, Wang Y, Dodman A, El-Khairi M, Gorni K, Jaber B, Kletzl H, Gaki E, Fontoura P, Darras BT; FIREFISH Study Group. Masson R, et al. Lancet Neurol. 2022 Dec;21(12):1110-1119. doi: 10.1016/S1474-4422(22)00339-8. Epub 2022 Oct 14. Lancet Neurol. 2022. PMID: 36244364 Clinical Trial.
Visual aspects of Behçet's disease.
Kansu T, Kadayifcilar S. Kansu T, et al. Among authors: kadayifcilar s. Curr Neurol Neurosci Rep. 2005 Sep;5(5):382-8. doi: 10.1007/s11910-005-0062-8. Curr Neurol Neurosci Rep. 2005. PMID: 16131421 Review.
Prepapillary vascular loop-a new classification.
Mansour AM, Kozak I, Saatci AO, Ascaso FJ, Broc L, Battaglia M, Olivier N, Gili P, Chhablani J, Hedges TR, Honrubia A, Gutierrez L, Panozzo G, Català J, Díaz J, Carreras E, Kadayifcilar S, Al Kahtani ES, Uwaydat SH, Lima LH, Mansour HA, Khan HA, Aaberg TM Jr, Bovino JA, Hunyor AP. Mansour AM, et al. Among authors: kadayifcilar s. Eye (Lond). 2021 Feb;35(2):425-432. doi: 10.1038/s41433-020-0859-3. Epub 2020 Apr 14. Eye (Lond). 2021. PMID: 32291404 Free PMC article.
Rheumatic inflammatory eye diseases of childhood.
Reiff A, Kadayifcilar S, Özen S. Reiff A, et al. Among authors: kadayifcilar s. Rheum Dis Clin North Am. 2013 Nov;39(4):801-32. doi: 10.1016/j.rdc.2013.05.005. Epub 2013 Jul 13. Rheum Dis Clin North Am. 2013. PMID: 24182856 Review.
Current practice in the management of ocular toxoplasmosis.
Yogeswaran K, Furtado JM, Bodaghi B, Matthews JM; International Ocular Toxoplasmosis Study Group; Smith JR. Yogeswaran K, et al. Br J Ophthalmol. 2023 Jul;107(7):973-979. doi: 10.1136/bjophthalmol-2022-321091. Epub 2022 Feb 23. Br J Ophthalmol. 2023. PMID: 35197262
Visual aspects of Behçet's disease.
Kansu T, Kadayifcilar S. Kansu T, et al. Among authors: kadayifcilar s. Curr Treat Options Neurol. 2006 Jan;8(1):81-8. doi: 10.1007/s11940-996-0026-6. Curr Treat Options Neurol. 2006. PMID: 16343363
90 results